From SBA-financed full buyouts to earnouts tied to specialist retention, here's how deals actually get done in the veterinary specialty market — and what buyers and sellers need to know before signing.
Veterinary specialty practice acquisitions involve unique structural complexity that sets them apart from general practice veterinary deals. The value of these practices is tightly bound to board-certified specialists, referral relationships with general practitioners, and high-cost diagnostic infrastructure — all of which require careful deal architecture to protect both parties. A poorly structured deal can trigger specialist departures, referral network erosion, or DEA compliance gaps that destroy value within months of closing. The most successful transactions in this space use a combination of SBA 7(a) debt, earnout provisions tied to measurable clinical and referral outcomes, and equity rollovers that keep founding specialists financially invested in the practice's post-close performance. Purchase price multiples typically range from 4.5x to 7.5x EBITDA depending on specialist depth, referral diversification, equipment quality, and revenue trajectory. Understanding which structure fits your specific situation — whether you're a PE-backed consolidator, an individual veterinarian buyer, or a founding specialist approaching retirement — is the foundation of a successful transaction.
Find Veterinary Specialty Practice Businesses For SaleFull Acquisition with SBA 7(a) Financing
The buyer acquires 100% of the practice using an SBA 7(a) loan covering 80–90% of the purchase price, with the buyer contributing 10–15% equity injection. The seller exits fully at closing or remains in a short-term clinical transition role. This structure is most common when a founding specialist is retiring and the practice has documented financials, contracted staff specialists, and a diversified referral base that can survive the ownership change.
Pros
Cons
Best for: Retiring founding specialists with clean financials, contracted staff veterinarians who will remain post-close, and individual buyer-operators or small groups seeking straightforward SBA-financed acquisitions.
Full Acquisition with Seller Earnout
The buyer acquires 100% of the practice at close, but a meaningful portion of the total consideration — typically 15–25% — is deferred and paid out over 12–24 months based on the achievement of specific performance metrics. In veterinary specialty practices, earnout triggers are almost always tied to specialist retention, referral volume maintenance, and revenue thresholds rather than generic EBITDA targets.
Pros
Cons
Best for: Acquisitions where one or two specialists account for the majority of revenue, where the buyer needs protection against referral concentration risk, or where the seller's personal relationships with referring GPs are a critical component of practice value.
Partial Equity Rollover with Minority Stake
The seller receives a cash payment for 70–85% of the practice value at closing and retains a 15–30% equity stake in the continuing or combined entity. The selling specialist typically transitions into a clinical director or medical director role, maintaining patient relationships and referral network continuity while the buyer assumes operational and administrative control. This structure is most common in PE-backed roll-up acquisitions.
Pros
Cons
Best for: PE-backed consolidators acquiring anchor specialty practices, transactions where the founding specialist is under 60 and willing to continue practicing for 3–5 years, and acquisitions where referral network relationships are entirely relationship-dependent on the selling veterinarian.
Retiring Veterinary Oncologist — Full SBA Buyout
$2,800,000
SBA 7(a) loan: $2,380,000 (85%); Buyer equity injection: $420,000 (15%). Practice has $380,000 EBITDA on $2.1M revenue, yielding a 7.4x multiple reflecting two contracted staff oncologists, 28 active referring practices, and a recently upgraded linear accelerator and CT scanner.
Seller exits fully at close after a 90-day clinical transition period. SBA loan structured over 10 years at prevailing SBA rate. Lender requires 12-month escrow holdback of $140,000 (5% of purchase price) contingent on staff specialist retention through the first year post-close. No earnout. Seller signs a 3-year, 25-mile non-compete and a 12-month non-solicitation of referring practices.
Veterinary Surgery Practice — PE Acquisition with Earnout
$4,200,000 base + $630,000 earnout (15% of base)
Cash at close: $4,200,000 funded through PE equity and senior debt. Earnout: up to $630,000 payable over 24 months based on two equally weighted triggers — (1) retention of both board-certified surgeons through month 24, and (2) referral revenue from the top 15 referring practices not declining more than 10% versus the trailing 12-month average at close.
Selling veterinarian receives $4.2M at close and retains no equity. Earnout paid in two equal installments at months 12 and 24 based on audited performance against stated metrics. Seller agrees to remain as clinical director at market salary for 24 months. Non-compete: 3 years, 30-mile radius. Earnout metrics defined in a 4-page exhibit attached to the purchase agreement with monthly reporting obligations.
Veterinary Cardiology and Internal Medicine Clinic — PE Roll-Up with Equity Rollover
$5,500,000 total enterprise value
Cash at close: $3,850,000 (70% of enterprise value). Equity rollover: $1,650,000 in minority stake (30%) in the acquiring platform entity. Selling cardiologist receives cash proceeds and retains a 30% stake in the combined regional specialty group, which includes two other practices acquired in the prior 18 months.
Selling cardiologist transitions to Medical Director role at current compensation. Rollover equity governed by a shareholders agreement with standard drag-along, tag-along, and put/call provisions. Buyout of rollover stake triggered at the platform's next liquidity event (targeted 4–6 years) at the same multiple applied to the platform as a whole. Drag-along threshold: 75% majority holder vote. Non-compete tied to employment agreement duration plus 12 months post-departure.
Find Veterinary Specialty Practice Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
Veterinary specialty practices typically sell for 4.5x to 7.5x EBITDA, with the wide range reflecting meaningful differences in specialist depth, referral network diversification, equipment quality, and revenue trajectory. A single-specialist oncology practice with one dominant referring hospital will trade at the low end of that range due to concentration risk. A multi-disciplinary specialty hospital with three or more board-certified specialists across different disciplines, diversified referrals from 25+ general practices, and strong EBITDA margins above 20% can command 6.5x–7.5x. PE-backed strategic acquirers often pay at the higher end when the practice serves as an anchor in a regional roll-up platform.
Yes. Veterinary specialty practices are eligible for SBA 7(a) financing, and this is one of the most common funding structures for individual veterinarian buyers and small groups acquiring practices in the $1.5M–$4M purchase price range. The SBA will lend up to 80–90% of the purchase price, requiring a 10–15% equity injection from the buyer. However, SBA lenders will scrutinize specialist employment contract assignability, referral concentration risk, and DEA licensing continuity as part of credit underwriting. Buyers should work with SBA lenders who have prior experience with veterinary or healthcare service acquisitions, as the due diligence requirements are more complex than a standard small business acquisition.
An earnout in a veterinary specialty acquisition defers 10–25% of the total purchase price, paying that amount to the seller over 12–24 months only if specific performance thresholds are met after closing. Unlike general business earnouts tied to aggregate EBITDA, specialty veterinary earnouts are almost always structured around two specific risk factors: (1) specialist retention — whether key board-certified veterinarians remain employed and actively practicing through the earnout period, and (2) referral volume maintenance — whether revenue from the top referring general practices remains at or above a baseline established in the trailing 12 months before close. These metrics directly address the two primary sources of value erosion risk in specialty practice acquisitions.
Referral relationships in specialty veterinary medicine are primarily professional and personal — referring GPs send cases to specialists they trust clinically and with whom they have established communication patterns. When ownership changes to a PE-backed group, the primary risk is that referring GPs perceive a shift in clinical culture, responsiveness, or quality of communication that causes them to redirect cases to a competing specialty group. The best mitigation is a seller-controlled transition communications plan, a retention period where the founding specialist remains visibly engaged, and continuity of the specialist team that referring GPs already know. Buyers should budget for a formal referral relations program post-close, including regular site visits, continuing education events, and specialist liaison communications to reinforce relationship continuity.
The answer depends on your age, financial goals, and how long you are willing to remain clinically active. A full sale maximizes immediate liquidity and is appropriate for specialists approaching retirement or those seeking a clean exit from administrative and ownership responsibilities. A partial equity rollover — typically 15–30% of enterprise value retained as a minority stake in the acquiring platform — is compelling if you are under 60, plan to continue practicing for 3–5 more years, and believe the consolidating platform will grow to a future exit at a higher multiple than your current standalone practice commands. Many specialists who rolled equity into PE platforms in the last decade captured a second, larger liquidity event at platform sale. The risk is that rollover equity is illiquid until a liquidity event occurs, and minority protections must be negotiated carefully to prevent your stake from being diluted or undervalued at exit.
The most common deal-killers in this sector fall into four categories. First, unresolved DEA or state veterinary board compliance issues — controlled substance violations, expired licenses, or open investigations will either kill an SBA loan or require significant price concessions and escrow holdbacks. Second, specialist departure risk — if the primary revenue-generating specialist announces retirement or signals departure during due diligence without a credible succession plan in place, most buyers will retrade the price or walk. Third, undisclosed referral concentration — discovering post-LOI that 40% of revenue comes from a single referring hospital that has no formal agreement and is owned by a veterinarian approaching retirement is a material surprise that changes deal economics. Fourth, aging or poorly maintained diagnostic equipment — a CT scanner or MRI approaching end of useful life can represent $400,000–$1,200,000 in near-term capex that must be reflected in purchase price or deal structure.
More Veterinary Specialty Practice Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers